cancer news

Gay and bisexual black men are less likely to be tested for prostate cancer than men of any other racial and ethnic backgrounds regardless of their sexual orientation, according to a recent study by a researcher at Charles Drew University of Medicine and Science.In his study, published in the December issue of Medical Care, Kevin C. Heslin, an assistant professor at Charles Drew University, examined prostate and colorectal testing rates based on sexual orientation, race and ethnicity.read more

WASHINGTON (AP) -- Master toolmaker John McClain built machine parts with details so small they couldn't be seen with the naked eye. Then a lump on his neck turned out to be cancer....

In a study published in the Journal of the National Cancer Institute, vitamin D was tested to see whether it could reduce breast cancer risk in women. To the...

Bowel cancer screening will save more than 2,200 lives in the UK every year by 2025, researchers say.

The New York Times on Tuesday examined reconstructive breast surgery options provided to cancer patients undergoing mastectomies. According to the Times, despite recent advances in reconstructive breast surgery procedures, many plastic surgeons fail to inform women about the extent of their options.

Viralytics Limited (ASX: VLA) has received notice that publication of pre-clinical research data on the anti-cancer activity of its oncolytic virus candidate, EVATAKT (Echovirus type 1), will occur shortly in the internationally acclaimed 'Journal of Molecular Medicine'. The research was conducted by staff at the University of Newcastle on behalf of Viralytics.

Fred Hutchinson Cancer Research Center scientists Denise Galloway, Ph.D., a microbiologist, and Gerald Smith, Ph.D., a geneticist and microbiologist, have been awarded the distinction of AAAS Fellow. Election as a Fellow is an honor bestowed upon members of the American Association for the Advancement of Science, or AAAS, by their peers.

Title: Cancer Medicine Advances on Many FrontsCategory: health newscreated: 12/24/2008 2:00:00 AMLast Editorial Review: 12/24/2008

(University of Utah) Researchers at the University of Utah's Huntsman Cancer Institute have discovered two enzymes that, when combined, could be involved in the earliest stages of cancer. Manipulating these enzymes genetically might lead to targeted therapies aimed at slowing or preventing the onset of tumors.

(Charles Drew University of Medicine and Science) Gay and bisexual black men are less likely to be tested for prostate cancer than men of any other racial and ethnic backgrounds regardless of their sexual orientation.